Antitumour effect of RA 233 alone and combined with radiotherapy
- 1 January 1983
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 1 (2) , 181-190
- https://doi.org/10.1007/bf00121497
Abstract
The effect of RA233 alone or in combination with radiation was investigated in vivo on the 5180 sarcoma, the B16 melanoma and the Lewis lung carcinoma. The combined treatment was a significant improvement over radiation alone for the B16 and S180 tumours. RA233 alone did not influence the growth of these tumours. When the primary 3LL was irradiated, tumour size was unaffected but the number of pulmonary metastases was reduced. They were further reduced by the combination of RA233 and radiation. The number, volume and cytokinetics of the B16 cells and the 3LL cells were affected to varying degrees by RA233. The significance of these changes relative to the effects of RA233 are discussed.This publication has 7 references indexed in Scilit:
- Effect of RA233 alone and combined with radiation on experimental tumour metastasis. Part 1Clinical & Experimental Metastasis, 1983
- Failure of RA233 to Affect the Growth of Intravenously Injected Murine Lymphoma CellsPublished by Springer Nature ,1980
- Combination of radiation and razoxane (ICRF 159) in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1978
- PLATELET CANCER CELL-INTERACTION IN METASTASIS FORMATION - POSSIBLE THERAPEUTIC APPROACH TO METASTASIS PROPHYLAXIS1977
- The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL)Zeitschrift für Krebsforschung und Klinische Onkologie, 1976
- Platelets, Thrombosis and DrugsDrugs, 1975
- Synergism of ICRF 159 and radiotherapy in treatment of experimental tumorsCancer, 1974